Browse Diagnostic reagents industry topic

Subtopics (47)

Articles

1-100 out of 100 article(s)

Title	Author	Type	Date	Words
NeoPharm Presents the Phase I Data for Patients with Metastatic Solid Tumors.			Nov 17, 2009	776
Welch Allyn's John Moran Recognized at 2009 HIDA MedSurg Conference and Expo.		Conference news	Nov 5, 2009	591
NeoPharm Names Dr. Aquilur Rahman as President and CEO.			Oct 29, 2009	724
NeoPharm Submits Application for a Multicenter, Open-Label, Phase II Study of LE-DT for Locally Advanced or Metastatic Pancreatic Cancer Patients as a Frontline Treatment.			Oct 27, 2009	625
NeoPharm, Inc. Announces Third Quarter 2009 Financial Results and Clinical Trials Update.			Oct 26, 2009	1914
Quidel Announces Launch of Their MicroVue[R] C5a EIA Kit for Research Use Only.			Oct 16, 2009	978
Quidel Reports Third Quarter 2009 Results.		Financial report	Oct 16, 2009	1303
Hospitals, Healthcare Providers to Save with New Premier Agreements for Blood Bank Analyzers, Reagents, Consumables and Service.			Oct 9, 2009	204
Quidel Corporation Announces Joint Development and Commercialization Agreement with BioHelix Corporation.			Oct 6, 2009	849
New CEO bryant offers quick view of Quidel.	DiRamio, Denise		Oct 1, 2009	604
Quidel to Present at the William Blair & Company Emerging Growth Stock Conference.		Conference news	Sep 22, 2009	353
Quidel Issues Clarification Regarding Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Reactivity Information to the QuickVue Influenza A+B Test Package Insert.		Correction notice	Sep 18, 2009	729
Quidel Obtains Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Reactivity Information to the QuickVue Influenza A+B Test Package Insert.			Sep 17, 2009	738
Quidel to Present at Investor Conferences in September.		Conference news	Sep 10, 2009	500
Quidel Anticipates Record Quarterly Results Driven by Strong Demand for Flu Tests.		Financial report	Sep 10, 2009	1086
Swine flu concerns give biotechs shot in the arm: medical device makers see sales, stock prices soar.	Chambers, Heather		Sep 7, 2009	741
United States : Dyax receives $1.5 million payment as partner Eli Lilly's ImClone moves drug into development.			Aug 27, 2009	104
Dyax Announces Developments in Licensing and Funded Research Program.			Aug 26, 2009	1183
United States: Dyax Announces Developments in Licensing and Funded Research Program.			Aug 26, 2009	412
Quidel Launches Flu Test Educational Programs for the Clinical Community.			Aug 10, 2009	852
Quidel Announces Executive Appointments.			Aug 6, 2009	879
Science park tenant arrives.	Geiger, Daniel		Jul 29, 2009	656
NeoPharm, Inc. Announces Second Quarter 2009 Financial Results and Clinical Trials Update.			Jul 27, 2009	1983
Quidel Reports Second Quarter 2009 Results.		Financial report	Jul 22, 2009	1275
Quidel to Hold 2009 Second Quarter Conference Call on July 22, 2009.			Jul 9, 2009	379
Level 3 Expands Relationship with ImClone Systems.			Jun 29, 2009	696
Quidel Corporation to Attend the Sixth Annual Craig-Hallum Institutional Investor Conference.		Conference news	Jun 10, 2009	308
Reportlinker Adds Global In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015.			Jun 3, 2009	4668
Vical to sell $20m of stock and options.	Chambers, Heather	Brief article	Jun 1, 2009	125
Swine flu has firms working overtime: manufacturers reporting increased demand for products recently.	Chambers, Heather		May 11, 2009	732
NeoPharm, Inc. Provides ARS Update.			May 11, 2009	391
Chr. Hansen probiotics now in cheese.		Brief article	May 1, 2009	254
NeoPharm, Inc. Eliminates Preferred Rights Plan.			Apr 29, 2009	560
NeoPharm, Inc. Announces First Quarter 2009 Financial Results and Clinical Trial Update.			Apr 28, 2009	2065
Quidel Reports First Quarter 2009 Results.		Financial report	Apr 22, 2009	1039
Zila Names Jon Plexico to Board of Directors.			Apr 15, 2009	593
Molecular Templates Inc. Secures $2.5 Million in Series A Financing from Sante Ventures.			Apr 10, 2009	452
Quidel to Hold 2009 First Quarter Conference Call on April 22, 2009.			Apr 8, 2009	375
Quidel Announces Strategic Restructuring and Work Force Reduction.			Mar 31, 2009	880
Quidel Provides Update on Impact of Current Influenza Season and Macroeconomic Trends.			Mar 16, 2009	950
Quidel Schedules Conference Call for March 16, 2009 to Provide Business Update.			Mar 13, 2009	380
NeoPharm, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results.		Financial report	Mar 4, 2009	2248
Quidel Reports Fourth Quarter and Full Year 2008 Results.		Financial report	Feb 25, 2009	1369
Quidel Corporation Webinar Addresses Management of Influenza in Long-Term Care Facilities.			Feb 18, 2009	869
NeoPharm Submits Application for a Multicenter, Open-Label, Phase II Study of LE-DT for Castrate Resistant Prostate Cancer.			Feb 11, 2009	605
Significant Shareholder Calls upon Enzon to Immediately Add Two Candidates to the Board of Directors.			Feb 10, 2009	683
Quidel to Hold 2008 Fourth Quarter and Year-End Financial Results Conference Call on February 25, 2009.			Feb 10, 2009	392
NeoPharm, Inc. Reports Stock Delisted Prematurely.			Feb 5, 2009	595
Biothera Expands Metastatic Colorectal Cancer Trial.			Jan 29, 2009	458
Schaeffer's Street Stories: Eli Lilly & Co. Slips as Drug Sales Slow.			Jan 29, 2009	148
NeoPharm, Inc. Announces Voluntary Delisting from NASDAQ and Deregistration of Common Stock.			Jan 23, 2009	859
Flu Has Arrived in Dallas-Fort Worth Per the FluSTAR Flu Tracking and Reporting System1 and Local Public Health.			Jan 22, 2009	371
Quidel Corporation Appoints Douglas C. Bryant President & Chief Executive Officer.			Jan 20, 2009	842
Luminex Corporation Announces Organizational Change.			Jan 20, 2009	410
Quidel Launches rsvtesting.com; Web Site Delivers Practical Information on Respiratory Syncytial Virus (RSV).			Jan 19, 2009	964
NeoPharm, Inc. to Participate in the OneMedPlace Finance Forum in San Francisco, CA.			Jan 12, 2009	206
Quidel Corporation to Present at the 27th Annual J.P. Morgan Healthcare Conference.		Conference news	Jan 6, 2009	356
Miami-Dade Media Alert: Flu Has Arrived in Miami-Dade Per the FluSTAR Flu Tracking and Reporting System1 and Local Public Health.			Dec 22, 2008	369
Schaeffer's Street Stories: Eli Lilly & Co. Breaks Out of Trading Range.			Dec 11, 2008	75
Quidel's QuickVue[R] iFOB Test Results Show High Correlation with Quantitative Laboratory Assay for Fecal Occult Blood Using Stools from Patients with Post-Colonoscopy Based Clinical Diagnosis.			Dec 9, 2008	993
Avila Therapeutics Appoints Daniel S. Lynch as Executive Chairman.			Dec 5, 2008	523
Quidel Authorizes Additional $25 Million under Stock Repurchase Program.			Dec 2, 2008	383
Quidel to Present at the 20th Annual Piper Jaffray Healthcare Conference.		Conference news	Dec 1, 2008	348
NutriPhy Lingonberry 100.		Brief article	Dec 1, 2008	58
New Lab M minicat.		Brief article	Dec 1, 2008	68
Fitch Downgrades Eli Lilly & Co.'s IDR to 'A+'; Outlook Stable.			Nov 24, 2008	553
ImClone Systems' State-of-the-Art Manufacturing Facility Receives FDA Approval for Multi-Product Biologics Production.			Nov 20, 2008	821
Randomized Phase 2 Study of IMC-A12 for HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment.		Clinical report	Nov 19, 2008	1228
ImClone Systems Announces Clearance of Tender Offer by German Federal Cartel Office.			Nov 17, 2008	618
NeoPharm, Inc. Announces Third Quarter 2008 Financial Results.		Financial report	Nov 12, 2008	1446
Phase 2 Study of IMC-1121B in First-Line Treatment of Advanced Non-Small Cell Lung Cancer Commences Patient Enrollment.		Report	Nov 11, 2008	662
Quidel Announces Promotion of John Tamerius, Ph.D. to Senior Vice President, Clinical/Regulatory Affairs.			Nov 7, 2008	721
ImClone Systems Announces Expiration of Hart-Scott-Rodino Waiting Period.			Nov 5, 2008	611
ERBITUX(R) Supplemental Biologics License Application for First-Line Recurrent or Metastatic Head and Neck Cancer Accepted for Priority Review by U.S. Food and Drug Administration.			Oct 30, 2008	1489
Zacks Analyst Blog Highlights: PNC Financial Services Group, National City Corp., Eli Lilly & Co., Lockheed Martin Corp. and Valero Energy Corp.			Oct 29, 2008	729
NeoPharm Granted Extension to Regain Listing Compliance on NASDAQ.			Oct 24, 2008	516
Quidel Reports Third Quarter 2008 Results.			Oct 22, 2008	1397
Study Published in New England Journal of Medicine Shows K-ras Gene Mutation Status May Affect Response to ERBITUX(R) Treatment.		Clinical report	Oct 22, 2008	1502
NeoPharm Signs IL-13 Related CRADA with NINDS/ NIH for Research on the Therapeutic Agent for Untreatable Brain Diseases.			Oct 15, 2008	697
United States: Lilly to Acquire ImClone for USD6.5 billion.			Oct 11, 2008	220
Quidel Corporation Secures New $120 Million Credit Facility.			Oct 9, 2008	829
Quidel to Hold 2008 Third Quarter Conference Call on October 22, 2008.			Oct 8, 2008	378
United States: Lilly to acquire ImClone Systems for $6.5 billion.			Oct 8, 2008	294
Biothera Completes Enrollment of First Arm of Metastatic Colorectal Cancer Trial.			Oct 7, 2008	364
Zacks Analyst Blog Highlights: Bristol-Myers Squibb Co., ImClone Systems Inc., LSI Corp, Infineon Technologies A.G. and ConocoPhillips.			Oct 6, 2008	712
ImClone Announces Merger Agreement with Eli Lilly at $70 Per Share.			Oct 6, 2008	891
Bristol-Myers Squibb Comments on Eli Lilly as New Erbitux Marketing Partner.			Oct 6, 2008	304
Fitch Places Eli Lilly's 'AA' IDR on Watch Negative on ImClone Merger.			Oct 6, 2008	394
United States: ImClone Mystery Solved: Eli Lilly Bidding $6.1 Billion.			Oct 4, 2008	174
ImClone Systems Issues Statement.			Oct 2, 2008	365
Phase 2 Study of IMC-1121B for Advanced Ovarian Cancer Commences Patient Enrollment.			Sep 30, 2008	716
ImClone Systems Issues Statement.			Sep 29, 2008	390
United States: ImClone says begins Patient Enrollment for Phase 2 Study of IMC-A12 for Advanced Breast Cancer.		Clinical report	Sep 26, 2008	180
Randomized Phase 2 Study of IMC-A12 for Advanced Breast Cancer Commences Patient Enrollment.		Clinical report	Sep 25, 2008	780
BM sweetens bid for takeover of ImClone.			Sep 24, 2008	110
Bristol-Myers Squibb to Commence Cash Tender Offer for ImClone Systems at $62.00 per share.			Sep 22, 2008	1517
Corporate shaker Carl Icahn ups his ownership in Amylin.	Chambers, Heather	Brief article	Sep 22, 2008	325
Ortho-Clinical Diagnostics receives FDA approval for new HIV test.		Brief article	Jun 1, 2008	145
ImClone diversifies.		Brief article	Mar 1, 2008	203
ImClone Systems.		Brief article	Jan 1, 2007	44